Table 2.
Total (N = 120) | COVID-19 patients (n = 58) | Non-COVID-19 participants (n = 62) | p value | Effect size |
---|---|---|---|---|
COVID-19 symptoms and treatments | ||||
BCRSS (0/1/2/3) | 4/28/19/7 | NA | NA | NA |
Pneumonia (0/1) | 10/48 | 60/2 | 1.04×10−18 | χ2(1)=77.99 |
Respiratory rate>21 (yes/no) | 11/47 | 1/61 | 1.54×10−3 | χ2(1)=10.03 |
Fever (yes/no) | 29/29 | 9/53 | 2.97×10−5 | χ2(1)=17.44 |
GCS<15 (yes/no) | 38/20 | 35/27 | 0.31 | χ2(1) = 1.03 |
Oxygen therapy (yes/no) | 40/18 | 11/51 | 1.41×10−8 | χ2(1)=32.18 |
Antibiotic treatment (yes/no) | 43/15 | 17/45 | 3.14×10−7 | χ2(1)=26.16 |
Antiviral treatment (yes/no) | 41/17 | 1/61 | 2.23×10−15 | χ2(1)=62.85 |
qSOFA (0/1/2) | 19/29/10 | 27/34/1 | 1.10 × 10−2 | χ2(2) = 9.03 |
Neurological complications and confounding variables | ||||
Agitation (yes/no) | 25/33 | 10/52 | 1.20×10−3 | χ2(1)=10.55 |
Cerebrovascular event (yes/no) | 39/19 | 36/26 | 0.30 | χ2(1) = 1.08 |
Diabetes (yes/no) | 15/43 | 7/55 | 3.93 × 10−2 | χ2(1) = 4.25 |
Hypertension (yes/no) | 30/28 | 41/21 | 0.11 | χ2(1) = 2.57 |
Note, the p value and effect size are for COVID-19 vs. non-COVID-19 difference. Rows in bold are variables showing significant COVID-19 vs. non-COVID-19 difference (corrected for twelve tests)). Pneumonia value of 1 denotes COVID/interstitial pneumonia, and pneumonia value of 0 denotes other/no pneumonia. Abbreviations: GCS, Glasgow Coma Score; qSOFA, quick Sequential Organ Failure.